D-0355-2025 Class II Ongoing

Recalled by Somerset Therapeutics Private Limited — Bengaluru, N/A

FDA drug recall D-0355-2025 was initiated by Somerset Therapeutics Private Limited on Mar 21, 2025 and is designated Class II. Reason for recall: Lack of Assurance of Sterility: Media fill with bacterial contamination The recall status is ongoing. Affected quantity: 997 vials.

Recall details

Product Type
Drugs
Report Date
Apr 16, 2025
Initiation Date
Mar 21, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
997 vials

Product description

Haloperidol Decanoate Injection 50mg/mL, 1mL Single-Dose Vial, Rx Only, Manufactured for: Somerset Therapeutics, LLC, Somerset, NJ 08873, NDC 70069-381-01 (individual carton) and NDC 70069-381-10 (10x1 mL carton)

Reason for recall

Lack of Assurance of Sterility: Media fill with bacterial contamination

Distribution pattern

U.S. Nationwide

Code information

NDC 70069-381-01; A240467A, exp. date 07/2026; NDC 70069-381-10; A240467C, exp. date 07/2026

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0355-2025
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0355-2025. Report a data issue: hello@regdatalab.com.